These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 38903497)
1. Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors. Park SM; Chen CJ; Verdon DJ; Ooi MPY; Brooks AES; Martin RCW; Mathy JA; Emanuel PO; Dunbar PR Front Immunol; 2024; 15():1412076. PubMed ID: 38903497 [TBL] [Abstract][Full Text] [Related]
2. Is overexpression of CD163 and CD47 in tumour cells of breast carcinoma implicated in the recruitment of tumour-associated macrophages (TAMs) in tumour microenvironment? immunohistochemical prognostic study. Dawoud MM; Abd El Samie Aiad H; Kasem NS; El Khouly EA; Al-Sharaky DR J Immunoassay Immunochem; 2024 Jul; 45(4):342-361. PubMed ID: 38815282 [TBL] [Abstract][Full Text] [Related]
3. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1. Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569 [TBL] [Abstract][Full Text] [Related]
4. CD163 Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107 [TBL] [Abstract][Full Text] [Related]
5. Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1 Gok Yavuz B; Gunaydin G; Gedik ME; Kosemehmetoglu K; Karakoc D; Ozgur F; Guc D Sci Rep; 2019 Feb; 9(1):3172. PubMed ID: 30816272 [TBL] [Abstract][Full Text] [Related]
6. Engineering Endogenous Tumor-Associated Macrophage-Targeted Biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for Enhanced Chemo-Immunotherapy. Wang Y; Yu J; Luo Z; Shi Q; Liu G; Wu F; Wang Z; Huang Y; Zhou D Adv Mater; 2021 Oct; 33(39):e2103497. PubMed ID: 34387375 [TBL] [Abstract][Full Text] [Related]
7. M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway. Guo F; Kong W; Li D; Zhao G; Anwar M; Xia F; Zhang Y; Ma C; Ma X Eur J Med Res; 2024 Jul; 29(1):357. PubMed ID: 38970071 [TBL] [Abstract][Full Text] [Related]
8. Specific targeting of CD163 Etzerodt A; Tsalkitzi K; Maniecki M; Damsky W; Delfini M; Baudoin E; Moulin M; Bosenberg M; Graversen JH; Auphan-Anezin N; Moestrup SK; Lawrence T J Exp Med; 2019 Oct; 216(10):2394-2411. PubMed ID: 31375534 [TBL] [Abstract][Full Text] [Related]
9. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells. Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417 [TBL] [Abstract][Full Text] [Related]
10. PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages. Yamaguchi Y; Gibson J; Ou K; Lopez LS; Ng RH; Leggett N; Jonsson VD; Zarif JC; Lee PP; Wang X; Martinez C; Dorff TB; Forman SJ; Priceman SJ J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35738799 [TBL] [Abstract][Full Text] [Related]
11. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways. Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082 [TBL] [Abstract][Full Text] [Related]
12. Software-assisted morphometric and phenotype analyses of human peripheral blood monocyte-derived macrophages induced by a microenvironment model of human esophageal squamous cell carcinoma. Nishio M; Urakawa N; Shigeoka M; Takase N; Ichihara Y; Arai N; Koma Y; Yokozaki H Pathol Int; 2016 Feb; 66(2):83-93. PubMed ID: 26778807 [TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma. Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443 [TBL] [Abstract][Full Text] [Related]
14. Spatial interaction and functional status of CD68 Liu X; Zhang Z; Yuan J; Yu J; Chen D Front Immunol; 2024; 15():1396719. PubMed ID: 38799432 [TBL] [Abstract][Full Text] [Related]
15. CD163 Omilian AR; Cannioto R; Mendicino L; Stein L; Bshara W; Qin B; Bandera EV; Zeinomar N; Abrams SI; Hong CC; Yao S; Khoury T; Ambrosone CB Breast Cancer Res; 2024 May; 26(1):75. PubMed ID: 38720366 [TBL] [Abstract][Full Text] [Related]
16. Expression of Sox2 in breast cancer cells promotes the recruitment of M2 macrophages to tumor microenvironment. Mou W; Xu Y; Ye Y; Chen S; Li X; Gong K; Liu Y; Chen Y; Li X; Tian Y; Xiang R; Li N Cancer Lett; 2015 Mar; 358(2):115-123. PubMed ID: 25444903 [TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages. Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009 [TBL] [Abstract][Full Text] [Related]
18. Bladder cancer cells induce immunosuppression of T cells by supporting PD-L1 expression in tumour macrophages partially through interleukin 10. Wang X; Ni S; Chen Q; Ma L; Jiao Z; Wang C; Jia G Cell Biol Int; 2017 Feb; 41(2):177-186. PubMed ID: 27987237 [TBL] [Abstract][Full Text] [Related]
19. Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages. Stadler M; Pudelko K; Biermeier A; Walterskirchen N; Gaigneaux A; Weindorfer C; Harrer N; Klett H; Hengstschläger M; Schüler J; Sommergruber W; Oehler R; Bergmann M; Letellier E; Dolznig H Cancer Lett; 2021 Nov; 520():184-200. PubMed ID: 34256095 [TBL] [Abstract][Full Text] [Related]
20. Blocking LTB Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]